Pemetrexed
Pemetrexed
Pemetrexed (pronounced: peh-meh-TREX-ed) is a chemotherapy drug used in the treatment of certain types of cancer, including non-small cell lung cancer and mesothelioma. It is often used in combination with other chemotherapy drugs to enhance its effectiveness.
Etymology
The term "Pemetrexed" is derived from the chemical name for the drug, which is pemetrexed disodium. The name is a combination of the Greek words pemeto meaning "to inhibit" and xedis meaning "sodium". This refers to the drug's mechanism of action, which involves inhibiting the growth of cancer cells by interfering with their sodium channels.
Usage
Pemetrexed is administered intravenously, usually once every three weeks. The dosage is determined by the patient's body surface area, which is calculated using their height and weight. Pemetrexed is often given in combination with cisplatin, another chemotherapy drug.
Side Effects
Common side effects of pemetrexed include fatigue, nausea, vomiting, and loss of appetite. More serious side effects can include low blood cell counts, which can lead to an increased risk of infection, bleeding, and anemia.
Related Terms
External links
- Medical encyclopedia article on Pemetrexed
- Wikipedia's article - Pemetrexed
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski